Minerva Neurosciences Stock Net Income
| NERV Stock | USD 2.26 0.02 0.89% |
Minerva Neurosciences fundamentals help investors to digest information that contributes to Minerva Neurosciences' financial success or failures. It also enables traders to predict the movement of Minerva Stock. The fundamental analysis module provides a way to measure Minerva Neurosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Minerva Neurosciences stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -30 M | -31.5 M | |
| Net Loss | -27.7 M | -29.1 M | |
| Net Loss | -36.9 M | -38.8 M | |
| Net Loss | (4.61) | (4.84) | |
| Net Income Per E B T | 1.09 | 0.78 |
Minerva | Net Income |
Minerva Neurosciences Company Net Income Analysis
Minerva Neurosciences' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Minerva Neurosciences Net Income | (30.01 M) |
Most of Minerva Neurosciences' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Minerva Neurosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Minerva Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Minerva Neurosciences is extremely important. It helps to project a fair market value of Minerva Stock properly, considering its historical fundamentals such as Net Income. Since Minerva Neurosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Minerva Neurosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Minerva Neurosciences' interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Minerva Neurosciences reported net income of (30.01 Million). This is 108.79% lower than that of the Biotechnology sector and 142.84% lower than that of the Health Care industry. The net income for all United States stocks is 105.26% higher than that of the company.
Minerva Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Minerva Neurosciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Minerva Neurosciences could also be used in its relative valuation, which is a method of valuing Minerva Neurosciences by comparing valuation metrics of similar companies.Minerva Neurosciences is currently under evaluation in net income category among its peers.
Minerva Neurosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Minerva Neurosciences from analyzing Minerva Neurosciences' financial statements. These drivers represent accounts that assess Minerva Neurosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Minerva Neurosciences' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 277.4M | 95.5M | 34.2M | 8.5M | 40.0M | 38.0M | |
| Enterprise Value | 256.3M | 70.3M | (26.5M) | 46.1M | 81.0M | 127.3M |
Minerva Neurosciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Minerva Neurosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Minerva Neurosciences' managers, analysts, and investors.Environmental | Governance | Social |
Minerva Neurosciences Institutional Holders
Institutional Holdings refers to the ownership stake in Minerva Neurosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Minerva Neurosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Minerva Neurosciences' value.| Shares | Tower Research Capital Llc | 2024-06-30 | 2.4 K | Wells Fargo & Co | 2024-06-30 | 1.9 K | Royal Bank Of Canada | 2024-06-30 | 1.8 K | Acadian Asset Management Llc | 2024-06-30 | 1.2 K | Tfc Financial Management | 2024-09-30 | 186 | Bank Of America Corp | 2024-06-30 | 169 | Sandy Spring Bank | 2024-06-30 | 100.0 | Northwestern Mutual Wealth Management Co | 2024-06-30 | 100.0 | Ubs Group Ag | 2024-06-30 | 10.0 | Federated Hermes Inc | 2024-09-30 | 1.4 M | Vanguard Group Inc | 2024-09-30 | 252.1 K |
Minerva Fundamentals
| Return On Equity | -6.75 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | (10.86 M) | ||||
| Shares Outstanding | 6.99 M | ||||
| Shares Owned By Insiders | 22.26 % | ||||
| Shares Owned By Institutions | 30.47 % | ||||
| Number Of Shares Shorted | 7.08 K | ||||
| Price To Earning | 69.58 X | ||||
| Price To Book | 2.68 X | ||||
| Price To Sales | 1.87 X | ||||
| Gross Profit | (16.84 M) | ||||
| EBITDA | (21.69 M) | ||||
| Net Income | (30.01 M) | ||||
| Cash And Equivalents | 40.22 M | ||||
| Cash Per Share | 7.53 X | ||||
| Total Debt | 82.02 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 20.41 X | ||||
| Book Value Per Share | (3.10) X | ||||
| Cash Flow From Operations | (14.78 M) | ||||
| Short Ratio | 0.50 X | ||||
| Earnings Per Share | (0.45) X | ||||
| Target Price | 5.0 | ||||
| Beta | 0.17 | ||||
| Market Capitalization | 15.67 M | ||||
| Total Asset | 56.9 M | ||||
| Retained Earnings | (396.82 M) | ||||
| Working Capital | 38.66 M | ||||
| Current Asset | 33.48 M | ||||
| Current Liabilities | 5.32 M | ||||
| Net Asset | 56.9 M |
About Minerva Neurosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Minerva Neurosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Minerva Neurosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Minerva Neurosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Minerva Stock Analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.